Nkcfo LLC Sanofi Transaction History

Nkcfo LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$50.95 - $55.2 $10.8 Million - $11.7 Million	-211,300 Reduced 98.47%	3,275 $176,000
Q4 2022 Jan 26, 2023	BUY	$38.86 - $48.55 $20,401 - $25,488	525 Added 0.25%	214,575 $10.4 Million
Q3 2022 Oct 19, 2022	BUY	$37.22 - $100.5 $122,826 - $331,650	3,300 Added 1.57%	214,050 $8.14 Million
Q2 2022 Jul 08, 2022	BUY	$48.99 - $57.46 $7.68 Million - $9 Million	156,700 Added 289.92%	210,750 $10.5 Million
Q1 2022 Apr 28, 2022	BUY	$48.48 - $53.65 $2.62 Million - $2.9 Million	54,050 New	54,050 $2.78 Million
Q2 2021 Jul 22, 2021	SELL	$49.36 - $54.25 $39,488 - $43,400	-800 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$40.83 - $45.43 $32,664 - $36,344	800 New	800 $35,000

810

267M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Nkcfo LLC, based on Form 13F filings with the SEC.

Stay updated on Nkcfo LLC with notifications on news.